COVID-19 Visitors Guidance

August 17, 2020 (updated July 1, 2021)

This information has been archived. Some or all of the information below is no longer accurate.

Updated: July 1, 2021

(Para leer esta guía en español, haga clic aquí Guía para visitantes del COVID-19)


This Guidance provides the framework for a visitor accessing UMB owned or occupied facilities to ensure consistency with health and safety practices of the University regarding COVID-19. The Guidance is intended to apply during academic semesters Summer 2021 and Fall 2021.


This Guidance applies to any visitor accessing UMB owned or occupied facilities. School and unit visitor policies must align with this Guidance while it is in effect. Schools and units without pre-approved visitor guidelines, should adhere to this Guidance.


This Guidance does not apply to UMB faculty, staff, or students, or to any person with an active and authorized UMB One Card. This Guidance also does not apply to campus contractors, subcontractors, vendors, or service providers (who are subject instead to the UMB Updated COVID-19 Guidance for Contractors).


  1. Visitor: A non-UMB faculty, staff, or student, who requires access to a UMB owned or operated facility. Visitor is an all-encompassing term, to include but not be limited to: visiting scholars and researchers (U.S. and international), clinical research subjects, community representatives and minors, Boards of Visitors, public officials, prospective or visiting students, clients, field placement and experiential learning representatives, guest lecturers, and volunteers. A visitor may be participating in activities related to studying or attending events.
  2. Sponsor: A UMB faculty, staff, or student who sponsors a visitor’s access onto campus.

Health and Safety Recommendations for Visitors:

1. When accessing UMB owned or operated facilities, all visitors must comply with the UMB Updated Face Covering Policy. That Policy outlines different requirements for a vaccinated and unvaccinated visitor. A visitor is not required to show proof of vaccination at this time.

a. A visitor who is not able to safely wear a face covering may be provided with a reasonable accommodation.

b. Sponsors must make their visitor(s) aware of COVID-19 safety and health guidelines, in addition to inquiring about the need for reasonable accommodations.

2. Sponsors are responsible for communicating to their international visitors arriving from overseas about compliance with guidelines of the S. Centers for Disease Control and Prevention (CDC), State of Maryland, and City of Baltimore, if applicable.

a. The sponsor should notify the Office of International Services if coordinating with an international visitor.

3. Children are not allowed on campus, except as part of an organized UMB program (for example, CURE scholars) or otherwise in exigent circumstances. The UMB minors’ policy should be followed.


1. A visitor should be accessing UMB owned or operated facilities only as a result of a scheduled visit.

a. However, if the visitor’s presence is usually unscheduled, alternate procedures can be created and approved by a Dean, VP, or designee.

2. The sponsor is responsible for coordinating, communicating, and maintaining compliance for visitor management requirements. The sponsor is responsible to assemble invitation details, visitor needs, number of visitors, date, location, and the nature of the visit. It is recommended that the sponsor maintain a roster of visitor attendance.

3. The sponsor is responsible for communicating expectations to visitors, as well as coordinating internally to receive approval for their visit.

4. Subject to a school or unit-specific plan that outlines a different process, a Dean, VP, or designee is responsible to review and inform the sponsor whether the visit is approved (or modifications are required). The sponsor should outline any risk factors that should be considered before the visit is approved, including date, time, and the visitor’s activity.

5. If more than 25 visitors are expected at one time per activity, the sponsor must notify the Recovery Task Force at

6. The sponsor is responsible to confirm the scheduled visit and to provide arrival instructions to the visitor.

7. A visitor participating in a clinical trial is expected to follow standard practices of care, which require participation in a medical evaluation the day before and the day of the scheduled visit.

8. The visitor should be instructed to arrive to the main entrance of the facility and check in at the security desk. The name of the visitor should be provided to the security officer in order to verify approved visits.

Administrative Notes

1. The Guidance is subject to change due to the evolving nature of COVID-19.

2. For questions about this Guidance, please email